Yoosakul, E.; Seeduang, C.; Chuasuwan, B.; Manamuti, C.; Pitisuttithum, P.; Karachot, B.; Techatanawat, I. Comparative Randomized, Single Dose, Two-Way Crossover, Open-Label Study to Determine the Bioequivalence of Irbesartan Formulation, Irbesartan GPO 150 Mg Tablets and Aprovel® 150 Mg Tablets, After Oral Administration to Healthy Thai Volunteers under Fasti. J Health Res 2017, 30, 199-205.